baber/WOPTO huggingface dataset:
Patent AU-3566595-A (AU)
Title: Fused indole and quinoxaline derivatives, their preparation and use
Inventor: MOLDT PETER
IPC: A61P9/00
Filed: 1995-09-12
Abstract: PCT No. PCT/EP95/03594 Sec. 371 Date May 20, 1997 Sec. 102(e) Date May 20, 1997 PCT Filed Sep. 12, 1995 PCT Pub. No. WO96/08495 PCT Pub. Date Mar. 21, 1996The present patent application discloses compounds having the formula   <IMAGE>   or a pharmaceutically acceptable salt thereof wherein R1 is hydrogen, alkyl or benzyl; X is O or NOR2, wherein R2 is hydrogen, alkyl or benzyl; Y is N-R4 wherein R4 is hydrogen, OH or alkyl; n is 0 or 1; R6 is phenyl which is substituted one or more times with substituents selected from the group consisting of SO2NR'R'', CONR'R'', and COR'''wherein R' and R'' each independently are hydrogen, alkyl, or -(CH2)p-W, wherein p is 0, 1, 2, 3, 4, 5, or 6, and W is hydroxy, amino, alkoxycarbonyl, or phenyl which may be substituted one or more times with substituents selected from the group consisting of halogen, CF3, NO2, amino, alkyl, alkoxy or methylenedioxy; or wherein R' and R'' together is (CH2)rZ(CH2)s wherein r and s each independently are 0, 1, 2, 3, 4, 5, or 6 and Z is O, S, CH2 or NR'''' wherein R'''' is hydrogen, alkyl, or -(CH2)p-W, wherein p is 0, 1, 2, 3, 4, 5, or 6, and W is hydroxy, amino, alkoxycarbonyl, or phenyl which may be substituted one or more times with substituents selected from the group consisting of halogen, CF3, NO2, amino, alkyl, alkoxy or methylenedioxy; and wherein R''' is hydrogen, alkyl, alkoxy or phenyl which may be substituted one or more times with substituents selected from the group consisting of halogen, CF3, NO2, amino, alkyl, alkoxy or methylenedioxy; A is a ring of five to seven atoms fused with the benzo ring at the positions marked a and b. The compounds are useful in the treatment of cerebrovascular disorders for example.
Patent AU-3695993-A (AU)
Title: Novel fungal protease
IPC: C12N9/62
Filed: 1993-04-15
Abstract: The present invention concerns a novel DNA sequence coding for an Aspergillus serine protease of the subtilisin-type, an Aspergillus serine protease of the subtilisin-type per se and a method for the preparation thereof. The invention further concerns a novel Aspergillus mutant strain defective in a serine protease of the subtilisin-type, which is useful for the expression of heterologous protein, and a method for the preparation of such a mutant strain.
Patent AU-3787985-A (AU)
Title: Hygienic pad, process and plant for the production thereof
Inventor: AXEL FRIESE
IPC: A61F13/20
Filed: 1984-12-14
Abstract: The invention relates to a tampon (10), to the essentially cylindrical circumferential surface of which a liquid-permeable, thermoplastic material is fastened, with the application of pressure and heat. The dome-like constriction (10b) at the introduction end (10a) and the withdrawal end (10c) of the tampon (10) remain free of the liquid-permeable, thermoplastic material. The fastening of the liquid-permeable material to the outer surface of the absorbent material of the tampon (10), which consists of a nonwoven ribbon section rolled up on itself and pressed radially to give the final form of the tampon (10), guarantees that the high absorbency of the nonwoven fibre material, based on capillary action, continues through the liquid-permeable, thermoplastic material onto its outside. In addition, the liquid-permeable material offers protection against fibres becoming detached and makes it easier to introduce the tampon into and remove it from the body cavity.
Patent AU-3988885-A (AU)
Title: Stable fiber optic polarizer
Inventor: PAVLATH GEORGE A
IPC: G02B5/30
Filed: 1985-03-15
Abstract: This invention relates to fiber optic apparatus and methods for polarizing light for use in fiber optic devices, such as rotation sensors. A phase grating (52) formed of alternating layers of dielectrics (54,56) having different indices of refraction is placed adjacent a half coupler (12) that includes a fiber (20,22) having a cladding thickness which forms an interaction region. The evanescent field of light of a selected polarization interacts with the phase grating (52) to couple out of the fiber (20,22) while light of a second selected polarization remains in the fiber (20,22).
Patent AU-4061700-A (AU)
Title: Space management for managing high capacity nonvolatile memory
Inventor: ESTAKHRI PETRO
IPC: G11C8/12
Filed: 2000-03-30
Abstract: A controller device (10) includes a space manager circuit (28) responsive to address information from a host (22) and operative to read, write and erase information in a nonvolatile memory unit (16) based on the host address information. The space manager circuit (28) assigns a predetermined number of blocks (202,204,206,208) in sequential order to each of the nonvolatile memory device, forms super block, each super block having blocks arranged in parallel, identifies a particular super block having at least two blocks, a first block being located in a first nonvolatile memory device and a second block being located in a second nonvolatile memory device, for erasure of the particular super block.
Patent AU-4065593-A (AU)
Title: Novel tricyclic thiazolo and thiazino derivatives and anti-viral medicaments containing them
Inventor: MERTENS ALFRED
IPC: A61K31/505
Filed: 1993-05-07
Abstract: The present invention relates to tricyclic thiazolo and thiazino derivatives of formula (I) in which A is a carbocyclic or heterocyclic ring, X may be an oxygen or sulphur atom or the group =NH, =N-C1?-C6? alkyl or =S(O)2?, R is an aliphatic radical with 1-9 C atoms, which may be substituted by phenyl, or a carbocyclic ring with 7-15 C atoms or a heterocyclic ring system, R?1 is a hydrogen atom, an aliphatic radical with 1-6 C atoms or C1?-C6? alkoxy, C1?-C6? alkylmercapto, C1?-C6? alkylsulphinyl, C1?-C6? alkylsulphonyl, amino, C1?-C6? alkylamino, di-C1?-C6? alkylamino, sulphonamido, C1?-C6? alkoxycarbonyl, carboxy, halogen, hydroxy, nitro, cyano, azido, phenyl or benzyloxy, R?2, R?3, R?4 and R?5 may be hydrogen, C1?-C6? alkyl, C1?-C6? hydroxyalkyl, cyano, carboxy or C1?-C6? alkoxycarbonyl and R?2 and R?4 are a further bond between the C atoms to which they are bonded, R?6 is hydrogen or C1?-C6? alkyl, n is 0, 1 or 2 and m is 0 or 1, and their tautomers, enantiomers, diastereomers or physiological acceptable salts. The invention also relates to medicaments containing compounds of formula (I), especially for the treatment of viral infections.
Patent AU-4165196-A (AU)
Title: Electrotransport delivery device
Inventor: MCNICHOLS LARRY A
IPC: A61N1/30
Filed: 1995-11-27
Abstract: An electrotransport delivery device (410) includes control circuitry for discontinuously delivering a beneficial agent (eg, a drug) through a body surface (eg, skin 400). For example, the device may be the type which is manually activated by the patient or other medical personnel to activate electrotransport drug delivery. Once electrotransport delivery has been activated, a timer (221) counts a transition interval, typically about one minute, during which the device is allowed to operate and the impedance of the body surface (400) is allowed to stabilize. Thereafter, the electrotransport current and voltage are then monitored and compared to predetermined limits. Allowing for the transition interval permits tighter tolerances in monitoring the applied current.
Patent AU-4180896-A (AU)
Title: Device for the transdermal administration of medicaments to treat the male erectile impotence
Inventor: MILLOT PHILIPPE
IPC: A61N1/30
Filed: 1995-11-16
Abstract: PCT No. PCT/FR95/01510 Sec. 371 Date May 12, 1997 Sec. 102(e) Date May 12, 1997 PCT Filed Nov. 16, 1995 PCT Pub. No. WO96/14897 PCT Pub. Date May 23, 1996A device for the percutaneous administration of a medicament for treating male impotence comprises two reservoirs (1,2) hydratable with a medicament solution and intended to be applied to the skin of the penis. The reservoirs are mounted on substantially cylindrical bracelet-shaped means (8) with an elastically expansible diameter to support and press the reservoirs (1,2) against said skin during the treatment. The device includes a sensor which is fixed on the bracelet and is sensitive to the expansion of the bracelet in order to deliver a signal to the user.
Patent AU-4253801-A (AU)
Title: Sequence regulating the anther-specific expression of a gene and its use in the production of androsterile plants and hybrid seeds
Inventor: JIMENEZ MARIA DOLORES GOMEZ
IPC: C07K14/415
Filed: 2001-03-30
Abstract: The regulatory sequence is useful for the specific expression in anther of a nucleotide sequence of interest, for example, a sequence whose controlled expression under said regulatory sequence causes complete ablation of the anther in the early development stages and allows to obtain androsterile plants that are useful for producing hybrid seeds.
Patent AU-4256285-A (AU)
Title: Decorative panel with improved surface characteristics
Inventor: HOEVEN JOHANNES CHRISTIANUS WI
IPC: B05D3/06
Filed: 1985-05-16
Abstract: The decorative panel having an underlay or core layer and a decorative layer on one or both sides of the core. At least one of the two surfaces of at least the outermost layer of the panel comprises a synthetic resin of one or more radiation-polymerized components selected from unsaturated acrylates and methacrylates. This layer, when scratched, has a scratch resistance of at least 1.5 N and preferably 2 to 7 N (DIN 53 799, part 10). In the method for manufacturing the decorative panel, a liquid surface layer which includes the radiation-polymerizable components is applied onto an underlay and then polymerized by means of radiation. In a further step, the radiation-polymerized surface layer is pressed together with the underlay at an elevated temperature.
Patent AU-4279996-A (AU)
Title: New method for identifying and evaluating biologically active molecules
Inventor: SCHREIBER STUART L
IPC: G01N33/531
Filed: 1995-11-01
Abstract: This invention concerns materials, methods and applications relating to the multimerizing of protein mediators of biological events using synthetic, preferably non-peptidic, dimerizing agents or CIDs.
Patent AU-4296189-A (AU)
Title: Shelf board fitting
Inventor: WALZ RUDIGER
IPC: F16B12/20
Filed: 1989-10-17
Abstract: For fastening shelves (1) onto wall parts (2), a bracket (4), which is pushed by a groove (14), a slit or the like onto a usually hook- shaped fastening element (12), is pushed into the shelf (1). A blow against the shelf (1) from below may cause it to become unhooked unintentionally. In order to provide a fitting of simple construction for shelves (1) with which unintentional lifting out is avoided, the fastening element (12) has a groove-like depression (19) running transversely to its pushing-in direction (18) and there is swivel- mounted in the bracket (4) a locking disc (8), which is designed to engage in the depression and releases the fastening element (12) in the disengaged swivel position. 
<IMAGE>
Patent AU-4426201-A (AU)
Title: Solid perfumed preparation in the form of microbeads and use thereof
Inventor: MANE JEAN
IPC: A61L9/012
Filed: 2001-03-16
Abstract: The invention concerns a solid perfumed preparation with high persistency in the form of microbeads and comprising a volatile aromatic raw material, or a mixture of volatile aromatic raw materials, and one or several fusible excipients. Said preparation can further comprise one of the following constituents: one or more polymers dispersible in the melted mass formed by the constituents of the preparation, one or more mineral additives, one or more surfactants, one or more antioxidants, one or more colouring agents. The invention can be used in cosmetics and in household product industries.
Patent AU-4485200-A (AU)
Title: Tribonectins
Inventor: JAY GREGORY D
IPC: A61P41/00
Filed: 2000-04-24
Abstract: The invention features a tribonectin and a method of tribosupplementation carried out by administering tribonectins directly to an injured or arthritic joint.
Patent AU-4753297-A (AU)
Title: Peptide compositions with growth factor-like activity
Inventor: BHATNAGAR RAJENDRA S
IPC: A61P17/02
Filed: 1997-10-10
Abstract: Small peptide mimics of TGF- beta , having the general sequence AAi-AAi+1-AAi+2 followed by AAi+n shortly thereafter, have been prepared. In this sequence, AAi is alanine, asparagine, or leucine, AAi+1 is valine or isoleucine, AAi+2 is alanine, n is 3, 4, or 5 such that there are n-3 amino acid residues in between AAi+2 and AAi+n, and AAi+n is glutamic acid, aspartic acid, glutamine or asparagine. Because the essential requirement for TGF- beta  activity is the peptide's ability to form a stable  beta -bend structure under physiologic conditions, the inventive peptides are collectively referred to as  beta -bend peptides. Compositions for applications such as tissue repair are also provided that comprise a biocompatible matrix having cytomodulin or a cytomodulin analog admixed with or carried by the matrix.
Patent AU-4913300-A (AU)
Title: Device for cutting two or more rods or strips arranged one after the other
Inventor: GERSDORF OLIVER
IPC: B26D1/09
Filed: 2000-04-20
Abstract: The invention relates to a device for cutting two or more rods or strips arranged one after the other, especially driving rods and stamped rails of driving rod iron works. In order to produce a device which can be widely used, said device is provided with a second opening which is formed opposite a first opening of the device for the introduction of said rod.
Patent AU-4921299-A (AU)
Title: Screening device and method of screening an immunoassay test
Inventor: JONES OSBORN PIERCE
IPC: G01N33/53
Filed: 1999-07-14
Abstract: A screening device for performing an immunoassay test to detect the presence of a compound in a body fluid. The device includes a holder for removably receiving a membrane to which the fluid has been applied. Light is directed to the membrane. A photodetector measures the concentration of the light reflected back from the membrane. Specifically, the concentrations of reflected light from a control zone and a test zone are measured. Signals representative of the measured light concentrations are applied to a processor. If a specified concentration of predetermined light from a control zone on the membrane is detected, the processor considers the test to be successful. In the test is successful, the processor, based upon the measured concentration of reflected light from the test zone, generates data representative of the presence of the compound.
Patent AU-4927993-A (AU)
Title: Determination of the extent of cross-linking prior to the intentional curing of polymers
Inventor: STRONG A BRENT
IPC: G01N33/32
Filed: 1993-09-20
Abstract: A method for detecting extent of cross-linking of a high impedance polymer material during a pre-cure stage, the method comprising the steps of: a) applying a test signal through a sensor to the polymer material in the pre-cure stage to determine a level of impedance and corresponding sample voltage representative of a degree of cross-linking within the material; b) applying the same test signal through the sensor to a reference material having a fixed resistance to determine a reference voltage; c) determining a voltage difference between the test signal applied to the polymer at pre-cure stage and the test signal applied to the reference material as the reference voltage; d) correlating the voltage difference as a relative indicator of the extent of cross-linking which has occurred within the polymer material, based on comparison of magnitude of the voltage difference with respect to a comparable potential range of impedance for the polymer material from its lower impedance stage at minimal cross-linking to its high impedance stage at maximum impedance for total cross-linking.
Patent AU-4961200-A (AU)
Title: Integral lens for high energy particle flow, method for producing such lenses and use thereof in analysis devices and devices for radiation therapy and lithography
Inventor: KUMAKHOV MURADIN ABUBEKIROVICH
IPC: G01N23/223
Filed: 2000-05-30
Abstract: The inventions make possible to increase the degree of radiation focusing by the lens, to use particles of higher energies, and to increase the coefficients, depending on these factors, of the devices, the lens is used in. Thus the sublens 18 of the least degree of integration represents a package of the channels 5, which is growing out of joint drawing and forming the capillaries, which are laid in a bundle. The sublens of each higher degree of integration represents a package of sublenses of the previous degree of integration, which is growing out of their joint drawing and forming. The sublenses are growing out of performing the said operations at the pressure of the gaseous medium inside the channels being higher than the pressure in the space between the sublenses of the previous degree of integration and at the temperature of their material softening and splicing the walls.  To produce the lenses a bundle of stocks (capillaries) in a tubular envelope is fed to the furnace (at the first stage) or stocks, produced on the previous degree, and the said bundle is drawing from the furnace at the speed, exceeding the speed of feeding. The product is cut off on stocks for the next stage, and at the final stage the product is formed by varying the drawing speed, after what the parts with formed barrel-shaped thickenings are cut of.
Patent AU-5057501-A (AU)
Title: Compositions and methods for regulated protein expression in gut
Inventor: KIEFFER TIMOTHY J
IPC: A61K35/12
Filed: 2001-03-12
Abstract: The invention provides compositions and methods useful for treating disorders by producing a protein in a regulatable manner in a mucosal cell or tissue of an animal. The treatment methods include  in vivo  and  ex vivo  methods, including transplanting  in vitro  transformed cells that secrete the protein into a mammalian subject.
Patent AU-5225301-A (AU)
Title: A method for in vitro molecular evolution of antibody function
Inventor: OHLIN MATS
IPC: C07K16/00
Filed: 2001-04-04
Abstract: The present invention relates to a method for in vivo molecular evolution of antibody function. According to the present invention, a nucleic acid encoding a CDR that is normally contained in a framework (the “original framework”), which differs from a selected master framework, is amplified from an immunoglobulin gene and is inserted into a nucleic acid encoding the selected master framework. The invention further provides an antibody library, such as a phage display library, and methods of making the same.
Patent AU-5284699-A (AU)
Title: An anti-fraud closure device
Inventor: BATTEGAZZORE PIERO
IPC: B65D41/34
Filed: 1999-07-19
Abstract: An anti-fraud closure device for providing evidence of the initial opening of a container (2) for liquids comprising a pouring body (7), a connecting element (29), fixing means (12) for connecting the pouring body (7) to the neck (1) of the container, a removable cap (16) and an outer cap (19) disposed over and housing the cap (16). The device further includes a sleeve, a tubular element (35) inserted in the sleeve and connected thereto by means (38,42,43,44,45) for partial angular movement and for axial movement between a first and a second position and means (46) for indicating that the initial opening of the container has taken place. <IMAGE>
Patent AU-5319190-A (AU)
Title: Low linolenic acid oil producing flax cultivars
Inventor: GREEN ALLAN GRAHAM
IPC: A01H6/58
Filed: 1990-04-11
Abstract: The present invention provides flax cultivars having low linolenic acid content which produce seeds with similar low linolenic acid content. The flax cultivars are derived from flax seed having genetic mutations chemically induced by treatment with ethyl methane sulphonate at two unlinked loci exhibiting additive gene action. The induced mutations specifically affect the linoleic acid desaturation step in fatty acid biosynthesis.
Patent AU-5353294-A (AU)
Title: Disk array controller utilizing command descriptor blocks for control information
Inventor: CHANDLER GREGORY T
IPC: G06F13/12
Filed: 1993-10-04
Abstract: A disk array controller board which utilizes an EISA bus master which is a slave on its internal data bus to allow an advanced drive array controller chip (ADAC) to operate as a master. The ADAC is connected to transfer buffer RAM. The protocol of the internal data bus provides for a cycles to load a host memory address into the bus slave, to provide transfer count information and slave specific information and for a series of data transfer cycles. The local processor is connected to the EISA bus master and the ADAC to control operations and to provide certain information. The ADAC is controlled by structures referred to as command descriptor blocks (CDBs). Each CDB includes information which describes the various addresses, control bits and functional bits used by the ADAC to perform its transfer operations. The local processor directly writes and deposits data forming a CDB into the transfer buffer RAM. The ADAC obtains the CDB, loads the data into registers and then performs operations according to the information contained in these registers until a transfer is done. The ADAC itself performs operations, including automatic stripe scattering and gathering to develop contiguous host memory fields from striped array data. A series of CDBs can be chained so that a complex series of tasks can be developed. In one variation a string of CDBs is developed to transfer data but some data is transferred to the bit bucket, while other data is actually transferred.
Patent AU-5465194-A (AU)
Title: Mixtures of polymers of monoethylenically unsaturated dicarboxylic acids and polymers of ethylenically unsaturatedmonocarboxylic acids and/or polyaminocarboxylic acids, and the use of such mixtures
Inventor: PERNER JOHANNES
IPC: H04J3/24
Filed: 1993-11-11
Abstract: PCT No. PCT/EP93/03159 Sec. 371 Date May 22, 1995 Sec. 102(e) Date May 22, 1995 PCT Filed Nov. 11, 1993 PCT Pub. No. WO94/12571 PCT Pub. Date Jun. 9, 1994Mixtures of (I) polymers of monoethylenically unsaturated dicarboxylic acids having a molecular weight of from 200 to 5,000 and (II) (1) copolymers having a molecular weight of from 10,000 to 150,000 and comprising (a) from 10 to 70% by weight of monoethylenically unsaturated C4-C8-dicarboxylic acids or the salts thereof and (b) from 30 to 90% by weight of monoethylenically unsaturated C3-C10-monocarboxylic acids and/or the salts thereof, (2) graft polymers having a molecular weight of from 5,000 to 150,000, which are obtainable by free radical graft polymerization of (A) monoethylenically unsaturated C3-C10-carboxylic acids or the anhydrides and/or the salts thereof in the presence of (B) mono-, oligo- or polysaccharides and the derivatives thereof in a weight ratio (A) : (B) of (95 to 20) : (5 to 80), and/or (3) polyaminocarboxylic acids and/or polymers containing aminocarboxylic acid groups contain the components (I) and (II) in a weight ratio of from 10 : 0.5 to 0.5 : 10 and are used as additives for phosphate-free or low-phosphate textile detergents or as dispersants or coating inhibitors in cleaners for hard surfaces.
Patent AU-5577380-A (AU)
Title: Implantable infusion device
Inventor: PORTNER PEER MICHAEL
IPC: A61M5/00
Filed: 1980-02-21
Abstract: Multiple embodiments of an implantable infusion device for delivering precisely regulated dosages of drugs are disclosed, each device including reservoir means for containing the drug, catheter means for delivering the drug to the body and an actuating means which is responsive to a signal applied externally of the body for initiating delivery of a precisely regulated dosage. In one embodiment, the device is implanted subcutaneously to permit actuation by a solenoid driven element responsive to coded telemetry signal applied through the skin. In additional embodiments, the reservoir is pressurized for example, by means of vapor pressure or a mechanical spring, the drug under pressure in the reservoir being released in response to an externally applied signal.